Showing results (11-20 of 247) with videos related to
Sort By:
Pageof 25
Cancer Discovery|May 16, 2012
Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated deathInge Verbrugge, Ricky W JohnstoneClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Rational combinations using HDAC inhibitorsMichael Bots, Ricky W JohnstoneTransfusion Medicine Reviews|November 17, 2022
Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP)Melissa Chen, Jake ShorttInternational Journal of Cancer|February 26, 2016
Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse modelKelly Waldeck, Carleen Cullinane, Kerry Ardley, et al.British Journal of Haematology|May 30, 2024
Large cell lymphoma through a liquid lensJake Shortt, Stephen OpatCancer Research|December 3, 2015
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid LeukemiaAdele Baker, Gareth P Gregory, Inge Verbrugge, et al.The Journal of Clinical Investigation|January 3, 2014
New and emerging HDAC inhibitors for cancer treatmentAlison C West, Ricky W JohnstoneNature Reviews. Drug Discovery|August 19, 2014
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersKatrina J Falkenberg, Ricky W JohnstoneMethods in Molecular Biology (Clifton, N.J.)|January 12, 2018
A Comprehensive Protocol Resource for Performing Pooled shRNA and CRISPR ScreensLeonie A Cluse, Iva Nikolic, Deborah Knight, et al.The FEBS Journal|January 22, 2013
AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivoJennifer R Devlin, Katherine M Hannan, Pui Y Ng, et al.Pageof 25